GF86119038
Platinum
wire reel, 0.2m, diameter 1.0mm, as drawn, 99.99+%
Sinonimo/i:
Platinum, PT005155
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Scegli un formato
1 EA
CHF 958.00
Scegli un formato
Cambia visualizzazione
1 EA
CHF 958.00
About This Item
Formula empirica (notazione di Hill):
Pt
Numero CAS:
Peso molecolare:
195.08
Numero MDL:
Codice UNSPSC:
12141734
ID PubChem:
NACRES:
NA.23
Prodotti consigliati
Saggio
≥99.99%
Stato
wire
Produttore/marchio commerciale
Goodfellow 861-190-38
Resistività
10.6 μΩ-cm, 20°C
P. ebollizione
3827 °C (lit.)
Punto di fusione
1772 °C (lit.)
Densità
21.45 g/cm3 (lit.)
Stringa SMILE
[Pt]
InChI
1S/Pt
BASFCYQUMIYNBI-UHFFFAOYSA-N
Descrizione generale
For updated SDS information please visit www.goodfellow.com.
Note legali
Product of Goodfellow
Codice della classe di stoccaggio
13 - Non Combustible Solids
Classe di pericolosità dell'acqua (WGK)
nwg
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Scegli una delle versioni più recenti:
Certificati d'analisi (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.
Se ti serve aiuto, non esitare a contattarci Servizio Clienti
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Yanqin Cao et al.
Journal of nanoscience and nanotechnology, 14(2), 1194-1208 (2014-04-23)
Porous platinum, that has outstanding catalytic and electrical properties and superior resistant characteristics to corrosion, has been widely applied in chemical, petrochemical, pharmaceutical, electronic, and automotive industries. As the catalytic activity and selectivity depend on the size, shape and structure
Johnson J Liu et al.
Current cancer drug targets, 12(8), 962-986 (2012-07-17)
Membrane transporters govern the movement of drugs and their metabolites across biological membranes, thereby determining their pharmacokinetics, efficacy and adverse drug reactions. Platinum-based anticancer drugs are a mainstay of chemotherapy for many human malignancies. However, their clinical utility is limited
Dalian Ding et al.
Anatomical record (Hoboken, N.J. : 2007), 295(11), 1851-1867 (2012-10-10)
Cisplatin, carboplatin, nedaplatin, and oxaliplatin are widely used in contemporary oncology; however, their ototoxic and neurotoxic side effects are quite different as discussed in this review. Cisplatin is considered the most ototoxic, but despite its reputation, the magnitude of hair
Yanlong Yang et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(4), 2905-2921 (2013-12-18)
The relationship between the ERCC1/2 single nucleotide polymorphisms (SNPs) and the clinical outcomes of the platinum-based chemotherapy in the non-small cell lung cancer (NSCLC) is still inconsistent and inconclusive despite extensive investigations have been conducted to address this question. In
A G Quiroga
Journal of inorganic biochemistry, 114, 106-112 (2012-07-24)
This focused review is devoted to our advances in developing trans platinum complexes as antitumoral complexes, in particular those bearing aliphatic amines. It includes some fundamental aspects of the understanding of non conventional metallodrug mechanism. The perspective is arranged by
Active Filters
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.
